Vivos (RDGL) Cash from Financing Activities (2010 - 2025)
Vivos' (RDGL) quarterly Cash from Financing Activities came in at -$845.0 in Q4 2025, down 100.06% year-on-year from $1.5 million in Q4 2024, and down 100.06% quarter-over-quarter from $1.5 million in Q1 2025.
Vivos (RDGL) Cash from Financing Activities (2010 - 2025) Analysis & Trends
Vivos has disclosed Cash from Financing Activities across 15 years of filings, most recently posting -$845.0 for Q4 2025.
- Cash from Financing Activities for Q4 2025 came in at -$845.0, down 100.06% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.5 million (down 34.6% YoY), and the FY2025 annual result was $1.5 million, down 34.6% from the prior year.
- Cash from Financing Activities came in at -$845.0 for Q4 2025 at Vivos, down from $1.5 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $1.8 million in Q1 2021 to a low of -$145000.0 in Q4 2021.
- The 4-year median for Cash from Financing Activities is $518580.0 (2023), against an average of $667335.9.
- Peak annual rise in Cash from Financing Activities reached 2420.16% in 2021, while the deepest fall reached 111.56% in 2021.
- Vivos' Cash from Financing Activities stood at -$145000.0 in 2021, then surged by 457.64% to $518580.0 in 2023, then jumped by 182.56% to $1.5 million in 2024, then sank by 100.06% to -$845.0 in 2025.
- The last three Cash from Financing Activities figures came in at -$845.0 (Q4 2025), $1.5 million (Q1 2025), and $1.5 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -451.20 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 21.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | -25.00 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Vivos | - | - | -3,105.00 | -845.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -845.00 |
| Dec 31, 2025 | -845.00 |
| Mar 31, 2025 | 1.51 Mn |
| Mar 31, 2025 | 1.51 Mn |
| Dec 31, 2024 | 1.47 Mn |
| Dec 31, 2024 | 1.47 Mn |
| Jun 30, 2024 | 709,000.00 |
| Jun 30, 2024 | 709,000.00 |
| Mar 31, 2024 | 130,000.00 |
| Mar 31, 2024 | 130,000.00 |
| Dec 31, 2023 | 518,580.00 |
| Dec 31, 2023 | 518,580.00 |
| Sep 30, 2023 | 10,000.00 |
| Sep 30, 2023 | 10,000.00 |
| Dec 31, 2021 | -145,000.00 |
| Dec 31, 2021 | -145,000.00 |
| Mar 31, 2021 | 1.81 Mn |
| Mar 31, 2021 | 1.81 Mn |
| Dec 31, 2020 | 1.25 Mn |
| Dec 31, 2020 | 1.25 Mn |